5 Einträge gefunden

1. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
2. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
3. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

   1. Grupp, Katharina
   2. Boumesli, Rebecca
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Sauter, Guido

   2014 - Forschungsinformationssystem des UKE
4. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

   1. Grupp, Katharina
   2. Ospina-Klinck, Daniel
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Simon, Ronald

   2014 - Forschungsinformationssystem des UKE
5. High mitochondria content is associated with prostate cancer disease progression

   1. Grupp, Katharina
   2. Jedrzejewska, Karolina
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Quaas, Alexander

   2013 - Forschungsinformationssystem des UKE - frei zugänglich